FDA’s Woodcock Urges Patient Groups To Take Lead To Speed Regulatory Process, Development
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Medical and patient communities can help make up for FDA’s resource gaps by developing PRO standards and benefit-risk frameworks for specific diseases, FDA drug chief says.